Search Results - "Zhao, Juanjuan"

Refine Results
  1. 1

    Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview by Zhao, Juanjuan, Yang, Jun, Xie, Yan

    Published in International journal of pharmaceutics (30-10-2019)
    “…[Display omitted] Although flavonoid compounds have various pharmacological applications, they generally exhibit low oral bioavailability due to their poor…”
    Get full text
    Journal Article
  2. 2

    How to Build a Graph-Based Deep Learning Architecture in Traffic Domain: A Survey by Ye, Jiexia, Zhao, Juanjuan, Ye, Kejiang, Xu, Chengzhong

    “…In recent years, various deep learning architectures have been proposed to solve complex challenges (e.g. spatial dependency, temporal dependency) in traffic…”
    Get full text
    Journal Article
  3. 3

    Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 by Liao, Mingfeng, Liu, Yang, Yuan, Jing, Wen, Yanling, Xu, Gang, Zhao, Juanjuan, Cheng, Lin, Li, Jinxiu, Wang, Xin, Wang, Fuxiang, Liu, Lei, Amit, Ido, Zhang, Shuye, Zhang, Zheng

    Published in Nature medicine (01-06-2020)
    “…Respiratory immune characteristics associated with Coronavirus Disease 2019 (COVID-19) severity are currently unclear. We characterized bronchoalveolar lavage…”
    Get full text
    Journal Article
  4. 4

    Cytokine release syndrome: grading, modeling, and new therapy by Liu, Delong, Zhao, Juanjuan

    Published in Journal of hematology and oncology (24-09-2018)
    “…Genetically modified T cells that express a chimeric antigen receptor (CAR) are opening a new frontier in cancer immunotherapy. CAR T cells currently are in…”
    Get full text
    Journal Article
  5. 5

    Universal CARs, universal T cells, and universal CAR T cells by Zhao, Juanjuan, Lin, Quande, Song, Yongping, Liu, Delong

    Published in Journal of hematology and oncology (27-11-2018)
    “…Currently, the two approved T cell products with chimeric antigen receptors (CAR) are from autologous T cells. These CAR T cells approved for clinical use must…”
    Get full text
    Journal Article
  6. 6

    A New Cd(II)-Based Coordination Polymer for Efficient Photocatalytic Removal of Organic Dyes by Zhao, Juanjuan, Dang, Zhuoyu, Muddassir, Mohd, Raza, Saleem, Zhong, Aiguo, Wang, Xiaoxiong, Jin, Juncheng

    Published in Molecules (Basel, Switzerland) (28-09-2023)
    “…Coordination polymers (CPs) are a diverse class of multi-dimensional compounds that show promise as photocatalysts for degrading dyes in polluted water…”
    Get full text
    Journal Article
  7. 7

    Recent updates on CAR T clinical trials for multiple myeloma by Lin, Quande, Zhao, Juanjuan, Song, Yongping, Liu, Delong

    Published in Molecular cancer (05-11-2019)
    “…Proteasome inhibitors, immunomodulatory agents and monoclonal antibodies have dramatically changed the natural history of multiple myeloma (MM). However, most…”
    Get full text
    Journal Article
  8. 8

    Spatio-Temporal Analysis of Passenger Travel Patterns in Massive Smart Card Data by Zhao, Juanjuan, Qu, Qiang, Zhang, Fan, Xu, Chengzhong, Liu, Siyuan

    “…Metro systems have become one of the most important public transit services in cities. It is important to understand individual metro passengers'…”
    Get full text
    Journal Article
  9. 9

    Material machine learning for alloys: Applications, challenges and perspectives by Liu, Xiujuan, Xu, Pengcheng, Zhao, Juanjuan, Lu, Wencong, Li, Minjie, Wang, Gang

    Published in Journal of alloys and compounds (15-11-2022)
    “…Materials machine learning (ML) is revolutionizing various areas in a fast speed, aiming to efficiently design novel materials with superior performance. Here…”
    Get full text
    Journal Article
  10. 10

    Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry by Ge, Jiwan, Wang, Ruoke, Ju, Bin, Zhang, Qi, Sun, Jing, Chen, Peng, Zhang, Senyan, Tian, Yuling, Shan, Sisi, Cheng, Lin, Zhou, Bing, Song, Shuo, Zhao, Juanjuan, Wang, Haiyan, Shi, Xuanling, Ding, Qiang, Liu, Lei, Zhao, Jincun, Zhang, Zheng, Wang, Xinquan, Zhang, Linqi

    Published in Nature communications (11-01-2021)
    “…Understanding the mechanism for antibody neutralization of SARS-CoV-2 is critical for the development of effective therapeutics and vaccines. We recently…”
    Get full text
    Journal Article
  11. 11

    Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia by Zhao, Juanjuan, Song, Yongping, Liu, Delong

    Published in Journal of hematology and oncology (14-02-2019)
    “…The current treatment for pediatric acute lymphoblastic leukemia (ALL) is highly successful with high cure rate. However, the treatment of adult ALL remains a…”
    Get full text
    Journal Article
  12. 12

    Engineering switchable and programmable universal CARs for CAR T therapy by Liu, Delong, Zhao, Juanjuan, Song, Yongping

    Published in Journal of hematology and oncology (04-07-2019)
    “…A traditional chimeric antigen receptor (CAR) has a fixed design, and one type of CAR T cells can only target one antigen epitope. This rigid design limits…”
    Get full text
    Journal Article
  13. 13

    A new method of detecting pulmonary nodules with PET/CT based on an improved watershed algorithm by Zhao, Juanjuan, Ji, Guohua, Qiang, Yan, Han, Xiaohong, Pei, Bo, Shi, Zhenghao

    Published in PloS one (08-04-2015)
    “…Integrated 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) is widely performed for staging solitary pulmonary nodules…”
    Get full text
    Journal Article
  14. 14

    The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing by Xu, Gang, Qi, Furong, Li, Hanjie, Yang, Qianting, Wang, Haiyan, Wang, Xin, Liu, Xiaoju, Zhao, Juanjuan, Liao, Xuejiao, Liu, Yang, Liu, Lei, Zhang, Shuye, Zhang, Zheng

    Published in Cell discovery (20-10-2020)
    “…Understanding the mechanism that leads to immune dysfunction in severe coronavirus disease 2019 (COVID-19) is crucial for the development of effective…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Single-nucleus transcriptomic survey of cell diversity and functional maturation in postnatal mammalian hearts by Hu, Peng, Liu, Jian, Zhao, Juanjuan, Wilkins, Benjamin J, Lupino, Katherine, Wu, Hao, Pei, Liming

    Published in Genes & development (01-10-2018)
    “…A fundamental challenge in understanding cardiac biology and disease is that the remarkable heterogeneity in cell type composition and functional states have…”
    Get full text
    Journal Article
  17. 17

    Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human by Zhao, Juanjuan, Zhang, Shuye, Liu, Yang, He, Xiaomeng, Qu, Mengmeng, Xu, Gang, Wang, Hongbo, Huang, Man, Pan, Jing, Liu, Zhenwen, Li, Zhiwei, Liu, Lei, Zhang, Zheng

    Published in Cell discovery (28-04-2020)
    “…The liver plays a critical role in both immune defense and tolerance in the body. The liver-resident immune cells (LrICs) determine the immune properties, but…”
    Get full text
    Journal Article
  18. 18

    Laboratory Diagnosis and Monitoring the Viral Shedding of SARS-CoV-2 Infection by Yang, Yang, Yang, Minghui, Yuan, Jing, Wang, Fuxiang, Wang, Zhaoqin, Li, Jinxiu, Zhang, Mingxia, Xing, Li, Wei, Jinli, Peng, Ling, Wong, Gary, Zheng, Haixia, Wu, Weibo, Shen, Chenguang, Liao, Mingfeng, Feng, Kai, Li, Jianming, Yang, Qianting, Zhao, Juanjuan, Liu, Lei, Liu, Yingxia

    Published in Innovation (New York, NY) (25-11-2020)
    “…The worldwide epidemic of coronavirus disease 2019 (COVID-19) is ongoing. Rapid and accurate detection of the causative virus SARS-CoV-2 is vital for the…”
    Get full text
    Journal Article
  19. 19

    Bispecific antibodies targeting BCMA, GPRC5D, and FcRH5 for multiple myeloma therapy: latest updates from ASCO 2023 Annual Meeting by Zhao, Juanjuan, Ren, Quan, Liu, Xinyuan, Guo, Xiangqian, Song, Yongping

    Published in Journal of hematology and oncology (03-08-2023)
    “…Several bispecific antibodies (bsAbs) targeting BCMA, GPRC5D, and FcRH5 are in clinical trials for heavily pretreated multiple myeloma (MM) patients…”
    Get full text
    Journal Article
  20. 20

    CD20 × CD3 bispecific antibodies for lymphoma therapy: latest updates from ASCO 2023 annual meeting by Liu, Xinyuan, Zhao, Juanjuan, Guo, Xiangqian, Song, Yongping

    Published in Journal of hematology and oncology (03-08-2023)
    “…Multiple bispecific antibodies (bsAbs) have been approved for cancer immunotherapy. Several CD20 × CD3 bsAbs have demonstrated significant anti-B-cell…”
    Get full text
    Journal Article